Revelation Biosciences, Inc.
- Last sale
- Nov 12, 2026 · +3.55%
- Market cap
- $2.99M
- 683.44K shares
- Filings
- 390
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY24 yoy
Q3 2026N/M FY25 yoy
Q3 2026+64.6% FY25 yoy
- $2.99M
- —
- —
- 0.4×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2021 | — | $35.50M | $35.50M | — | 15.08M sh | +65.8% | — |
Pharmaceutical preparations
Revelation Biosciences, Inc. is the 474th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MDCXMedicus Pharma Ltd.———$3.3MERNAErnexa Therapeutics Inc.———$3.1MKALAKala Bio, Inc.$0.0——$3.1MCASIFCASI Pharmaceuticals, Inc.$20.7M27.4%232.0%$3.1M
REVBRevelation Biosciences, Inc. (this company)———$3.0M
GNPXGenprex, Inc.———$2.9MNXTSNexentis Technologies Inc.———$2.9MMBIOMustang Bio, Inc.———$2.8MISCOInternational Stem Cell CORP$9.1M0.2%4.6%$2.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Revelation Biosciences, Inc. · CIK 1810560 · Engraved from SEC EDGAR